Citation Impact

3 from Science/Nature 52 standout
Sub-graph 1 of 23

Citing Papers

A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma
2022 Standout
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
2022 Standout
1 intermediate paper

Works of Sharan Raghow being referenced

Toremifene – a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy
2006
Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
2000
and 1 more

Author Peers

Author PRM Genetics EDM Last Decade Papers Cites
Sharan Raghow 201 205 120 10 443
V. Venkat Raj 8 44 644
Paul Baines 19 92
R. W. G. White 267 3 35 785
Joanna Smoleń‐Dzirba 2 6 9 15 320
Alia Hasham 7 180 189 11 440

All Works

Loading papers...

Rankless by CCL
2026